Aerie Pharma (AERI) – Hot FDA News
-
Aerie Pharma (AERI) Announces AR-15512 Ophthalmic Solution Achieved Statistical Significance Over Multiple Symptoms in Phase 2b Clinical Study for Treatment of Dry Eye Disease
-
Aerie Pharma (AERI) Confirms FDA Approval of Rhopressa 0.02% for Lowering of Elevated IOP in Patients with Open-Angle Glaucoma or Ocular Hypertension
-
-
-
-
-
-
-
-
-
-
-
Back to AERI Stock Lookup